Sandoz Does Not Budge On 2022 Expectations Despite Positive Start

Q1 Revenues Improve By 8% At CCs While Bottom Line Soars – With Caveats

 
• By Dean Rudge
  
Profit
Sandoz enjoyed a huge bump in its core operating profit in Q1 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business